Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population.
Haight PJ, Barrington DA, Graves SM, Piver RN, Baek J, Ardizzone M, Akinduro JA, Busho AC, Fadoju D, Pandit R, Stephens R, Strowder LM, Tadepalli S, VanNoy B, Sriram B, McLaughlin EM, Lightfoot MDS, Bixel KL, Cohn DE, Cosgrove CM, O'Malley D, Salani R, Nagel CI, Backes FJ. Haight PJ, et al. Among authors: cosgrove cm. Gynecol Oncol. 2023 Mar;170:203-209. doi: 10.1016/j.ygyno.2023.01.013. Epub 2023 Jan 27. Gynecol Oncol. 2023. PMID: 36709661
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
Cosgrove CM, Cohn DE, Hampel H, Frankel WL, Jones D, McElroy JP, Suarez AA, Zhao W, Chen W, Salani R, Copeland LJ, O'Malley DM, Fowler JM, Yilmaz A, Chassen AS, Pearlman R, Goodfellow PJ, Backes FJ. Cosgrove CM, et al. Gynecol Oncol. 2017 Sep;146(3):588-595. doi: 10.1016/j.ygyno.2017.07.003. Epub 2017 Jul 11. Gynecol Oncol. 2017. PMID: 28709704 Free PMC article.
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT, Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ. Cosgrove CM, et al. Gynecol Oncol. 2018 Jan;148(1):174-180. doi: 10.1016/j.ygyno.2017.10.037. Epub 2017 Nov 11. Gynecol Oncol. 2018. PMID: 29132872 Free PMC article.
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.
Walker CJ, Rush CM, Dama P, O'Hern MJ, Cosgrove CM, Gillespie JL, Zingarelli RA, Smith B, Stein ME, Mutch DG, Shakya R, Chang CW, Selvendiran K, Song JW, Cohn DE, Goodfellow PJ. Walker CJ, et al. Among authors: cosgrove cm. J Natl Cancer Inst. 2018 May 1;110(5):517-526. doi: 10.1093/jnci/djx238. J Natl Cancer Inst. 2018. PMID: 29155953 Free PMC article.
Ovarian effects of radiation and cytotoxic chemotherapy damage.
Cosgrove CM, Salani R. Cosgrove CM, et al. Best Pract Res Clin Obstet Gynaecol. 2019 Feb;55:37-48. doi: 10.1016/j.bpobgyn.2018.07.008. Epub 2018 Jul 26. Best Pract Res Clin Obstet Gynaecol. 2019. PMID: 30166215 Review.
How safe is rucaparib in ovarian cancer?
Cosgrove CM, O'Malley DM. Cosgrove CM, et al. Expert Opin Drug Saf. 2018 Dec;17(12):1249-1255. doi: 10.1080/14740338.2018.1550067. Epub 2018 Dec 11. Expert Opin Drug Saf. 2018. PMID: 30449210 Review.
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab.
Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, Cosgrove CM, Davidson B, Thaker PH, Moore KN. Gillen J, et al. Among authors: cosgrove cm. Gynecol Oncol Rep. 2019 Oct 5;30:100502. doi: 10.1016/j.gore.2019.100502. eCollection 2019 Nov. Gynecol Oncol Rep. 2019. PMID: 31720357 Free PMC article.
75 results